LifeStance Health Group, Inc. (LFST)
After hours:
| Previous close | 6.16 |
| Open | 6.15 |
| Bid | 6.19 x 200 |
| Ask | 6.22 x 200 |
| Day's range | 6.06 - 6.25 |
| 52-week range | 4.74 - 9.59 |
| Volume | |
| Avg. volume | 1,353,909 |
| Market cap | 2.37B |
| Beta (5Y monthly) | 1.34 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
LifeStance to Host First Quarter 2024 Earnings Conference Call on May 9, 2024
SCOTTSDALE, Ariz., April 18, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, will issue its first quarter 2024 earnings release before the market opens on Thursday, May 9, 2024. LifeStance will host a live earnings conference call to discuss first quarter results on May 9, 2024, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internati
- PR Newswire
LifeStance Appoints Dr. Teresa DeLuca to Board of Directors
LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental healthcare, today announced that Dr. Teresa DeLuca has joined the company's board of directors. Dr. DeLuca is a psychiatrist and accomplished physician executive with over 20 years of leadership experience, having held senior executive leadership roles at Magellan Health, Humana and Walgreens, and brings extensive healthcare operations and clinical management expertise to LifeStance's board of dir
- GlobeNewswire
LifeStance Reports Fourth Quarter and Full Year 2023 Results
SCOTTSDALE, Ariz., Feb. 28, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the fourth quarter and full year ended December 31, 2023. (All results compared to prior-year comparative period, unless otherwise noted)2023 Highlights and 2024 Outlook Fourth quarter revenue of $280.6 million increased 22% and full year revenue of $1,055.7 million increased 23% compared to
